Chemed Corp. (NYSE: CHE) reported Q3 EPS of $1.78, $0.17 better than the analyst estimate of $1.61. Revenue for the quarter came in at $386 million versus the consensus estimate of $375.95 million.

Chemed Corp. sees FY2015 EPS of $6.75-$6.80, versus the consensus of $6.75.

For earnings history and earnings-related data on Chemed Corp. (CHE) click here.